Skip to content
Forensic Analysis · Retail / Consumer Discretionary · as of Nov 9, 2026

TheRealReal, Inc. (REAL)

A forensic read on TheRealReal, Inc. built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.

F · Poor — capital at risk
Forensic grade
Distress
Financial health
-11.8
Distress distance
Clean
Earnings quality
3
Forensic signals
15.4%
Revenue growth

This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (auditor quality, say on pay, board independence, going concern). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.

TheRealReal, Inc. earns an F (Poor — capital at risk) forensic quality grade, and its balance-sheet distress test reads -11.8, placing it in the Distress zone. 3 forensic signals were flagged in its latest SEC filings, led by return on invested capital.

What the filings flag

-105.6%
FY2024
Return on invested capital. Return on invested capital is -105.6% in the latest fiscal year, against -159.5% in FY2023. After-tax operating profit was ($131M) in FY2023 and ($45M) in FY2024, with operating income at -30.3% of revenue in FY2023 and -9.4% in FY2024. The capital base behind it came down -49% across FY2023–FY2024, from $82M to $42M, so this return is struck on a smaller base than it started on. FY2023's operating profit carried a $43M restructuring charge and a $40M asset write-down that alone took about 79.8 points off that year's return, so more than the whole 53.9-point rise across FY2023–FY2024 is that charge leaving the base year rather than the capital earning more. A non-cash write-down lowers the reported return in the year it lands.
+7.0%/yr
FY2023–FY2025
Share-count dilution. Diluted share count changed +14% over the last 2 years to FY2025 (+7.0%/yr). The count is growing — 101.8M shares in FY2023, 116.5M in FY2025: more stock was issued than repurchased over this window, so aggregate results grew faster than their per-share equivalents. That's ~7.0% shaved off per-share growth every year — total profit has to grow that much just to keep earnings-per-share flat, and a stake held since FY2023 has been diluted ~13%.
4% of rev
FY2025
Stock-based comp load. Stock-based compensation ran 4% of revenue and 528% of free cash flow in FY2025 — about $0.25 per diluted share. No cash left the business to pay it, which is why operating cash flow adds it back. Net of repurchases the diluted count still rose about 7.0% a year across FY2023–FY2025 and that rate is not falling, so total profit has to grow by that much annually before any of it reaches a share. Stock compensation is one source of that issuance; acquisition consideration, equity raises, convertibles and other employee plans also net into the count, and these figures do not separate them.

Key fundamentals

Latest Revenue$692.8M
Revenue Growth YoY+15.4%
Revenue CAGR (2yr)+12.3%
Net Margin-6.0%
Free Cash Flow$5.5M

The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from TheRealReal, Inc.'s actual 10-K/10-Q/8-K filings?

Generate the AI investment read →

No credit card · informational only, not investment advice · see the track record

← Browse all forensic stock analyses

Data from SEC EDGAR public filings · metrics as of Nov 9, 2026. Forensic signals flag probability, not certainty.

See a wrong number? Report an error with the filing it should match.